Venus Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2026 ,inter alia, to consider and approve The meeting of Board of Directors ....
VENUSREM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Venus Remedies has informed the exchanges that its Board of Directors will meet on 29 January 2026 to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31 December 2025. The company has also announced a trading window closure for designated persons from 1 January 2026 until 48 hours after the results are declared, in line with insider trading regulations. The results themselves are not part of this filing — only the meeting notice has been disclosed.
This is a routine regulatory filing and is not a material event on its own. The actual impact on shareholders will depend on the Q3 FY26 numbers (revenue, profit margins, etc.) to be disclosed on or after 29 January 2026.